PubMed Central, : RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2026; 17(3): e0019. ISSN: 2076-9172Published online 2026 July 31. doi: 10.5041/RMMJ.10579

Table 7.

Net Benefit at Clinically Relevant Thresholds (5%, 10%, 15%, 20%).

Threshold	FINDRISC		QDScore		TRAQ-D		Treat All	Treat None	Best Model
Threshold	Base	Base+ISI	Base	Base+ISI	Base	Base+ISI	Treat All	Treat None	Best Model
5%	0.040	0.044	0.037	0.041	0.032	0.035	0.024	0.000	FINDRISC: Base+ISI
10%	0.043	0.048	0.050	0.056	0.040	0.044	0.018	0.000	QDScore: Base+ISI
15%	0.020	0.027	0.037	0.045	0.022	0.028	0.012	0.000	QDScore: Base+ISI
20%	0.000	0.008	0.001	0.010	0.000	0.007	0.006	0.000	QDScore: Base+ISI

FINDRISC, Finnish Diabetes Risk Score; ISI, Insomnia Severity Index.

RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2026; 17(3): e0019. ISSN: 2076-9172

Published online 2026 July 31. doi: 10.5041/RMMJ.10579